Fortress Biotech Stock Price

-0.0293 (-4.16%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 178,841
Bid Price 0.644
Ask Price 0.675
News (1)
Day High 0.71


52 Week Range


Day Low 0.6351
Company Name Stock Ticker Symbol Market Type
Fortress Biotech Inc FBIO NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0293 -4.16% 0.675 19:24:02
Open Price Low Price High Price Close Price Prev Close
0.69 0.6351 0.71 0.6647 0.7043
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
808 178,841 $ 0.6651982 $ 118,965 - 0.62 - 2.87
Last Trade Time Type Quantity Stock Price Currency
19:58:07 1 $ 0.675 USD


Draw Mode:

Fortress Biotech Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 73.32M 108.62M 80.12M $ 68.79M $ - -0.79 -0.70
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 1.45M 28.40%

more financials information »

Fortress Biotech News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical FBIO Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.720.740.620.6660436381,829-0.045-6.25%
1 Month0.83690.88210.620.7271198195,868-0.1619-19.35%
3 Months1.121.140.620.7966723199,339-0.445-39.73%
6 Months0.921.3250.620.8992517371,128-0.245-26.63%
1 Year2.442.870.621.29448,466-1.77-72.34%
3 Years2.146.100.623.10754,549-1.47-68.46%
5 Years3.596.100.492.83587,682-2.92-81.2%

Fortress Biotech Description

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Targadox, Exelderm, Ceracade, Luxamend, and Dermasorb. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.